Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Factors associated with childhood influenza vaccination in Israel: a cross-sectional evaluation.

Glatman-Freedman A, Amir K, Dichtiar R, Zadka H, Vainer I, Karolinsky D, Enav T, Shohat T.

Isr J Health Policy Res. 2019 Nov 26;8(1):82. doi: 10.1186/s13584-019-0349-x.

2.

Nationwide epidemiology of early-onset sepsis in Israel 2010-2015, time to re-evaluate empiric treatment.

Glikman D, Curiel N, Glatman-Freedman A, Megged O, Youngster I, Marom R, Lavie K, Smolkin T, Troitzky M, Stein M; EOS Israeli study group.

Acta Paediatr. 2019 Dec;108(12):2192-2198. doi: 10.1111/apa.14889. Epub 2019 Aug 4.

PMID:
31168848
3.

Quadrivalent versus trivalent influenza vaccine: clinical outcomes in two influenza seasons, historical cohort study.

Shasha D, Valinsky L, Hershkowitz Sikron F, Glatman-Freedman A, Mandelboim M, Toledano A, Paran Y, Ben-Ami R, Goldman D.

Clin Microbiol Infect. 2019 May 17. pii: S1198-743X(19)30216-2. doi: 10.1016/j.cmi.2019.05.003. [Epub ahead of print]

PMID:
31108229
4.

A method to identify respiratory virus infections in clinical samples using next-generation sequencing.

Kustin T, Ling G, Sharabi S, Ram D, Friedman N, Zuckerman N, Bucris ED, Glatman-Freedman A, Stern A, Mandelboim M.

Sci Rep. 2019 Feb 22;9(1):2606. doi: 10.1038/s41598-018-37483-w.

5.

Hospitalization for Respiratory Syncytial Virus Bronchiolitis in the Palivizumab Prophylaxis Era: Need for Reconsideration of Preventive Timing and Eligibility.

Oz-Alcalay L, Ashkenazi S, Glatman-Freedman A, Weisman-Demri S, Lowenthal A, Livni G.

Isr Med Assoc J. 2019 Feb;21(2):110-115.

6.

Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.

Hirsch A, Katz MA, Laufer Peretz A, Greenberg D, Wendlandt R, Shemer Avni Y, Newes-Adeyi G, Gofer I, Leventer-Roberts M, Davidovitch N, Rosenthal A, Gur-Arie R, Hertz T, Glatman-Freedman A, Monto AS, Azziz-Baumgartner E, Ferdinands JM, Martin ET, Malosh RE, Neyra Quijandría JM, Levine M, Campbell W, Balicer R, Thompson MG; SHIRI workgroup.

BMC Infect Dis. 2018 Nov 6;18(1):550. doi: 10.1186/s12879-018-3444-7.

7.

Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.

Yaron-Yakoby H, Sefty H, Pando R, Dichtiar R, Katz MA, Stein Y, Mandelboim M, Mendelson E, Shohat T, Glatman-Freedman A; The Israeli Influenza Surveillance Network (IISN).

Euro Surveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00026.

8.

Forty five percent of the Israeli population were infected with the influenza B Victoria virus during the winter season 2015-16.

Sharabi S, Bassal R, Friedman N, Drori Y, Alter H, Glatman-Freedman A, Hindiyeh M, Cohen D, Mendelson E, Shohat T, Mandelboim M.

Oncotarget. 2017 Dec 22;9(5):6623-6629. doi: 10.18632/oncotarget.23601. eCollection 2018 Jan 19.

9.

Reply to Suzuki and Saito.

Stein Y, Glatman-Freedman A.

Clin Infect Dis. 2018 Aug 1;67(4):647. doi: 10.1093/cid/ciy108. No abstract available.

PMID:
29425264
10.

Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.

Stein Y, Mandelboim M, Sefty H, Pando R, Mendelson E, Shohat T, Glatman-Freedman A; Israeli Influenza Surveillance Network (IISN).

Clin Infect Dis. 2018 Apr 17;66(9):1383-1391. doi: 10.1093/cid/cix1013.

PMID:
29145568
11.

Influenza Season Hospitalization Trends in Israel: A Multi-Year Comparative Analysis 2005/2006 Through 2012/2013.

Glatman-Freedman A, Kaufman Z, Stein Y, Sefty H, Zadka H, Gordon B, Meron J, Gordon ES, Dichtiar R, Haklai Z, Afek A, Shohat T.

J Hosp Med. 2017 Sep;12(9):710-716. doi: 10.12788/jhm.2824.

PMID:
28914274
12.

Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel.

Glatman-Freedman A, Drori Y, Beni SA, Friedman N, Pando R, Sefty H, Tal I, McCauley J, Rahav G, Keller N, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

J Clin Virol. 2017 Aug;93:71-75. doi: 10.1016/j.jcv.2017.05.020. Epub 2017 Jun 4.

13.

West Nile virus outbreak in Israel in 2015: phylogenetic and geographic characterization in humans and mosquitoes.

Lustig Y, Kaufman Z, Mannasse B, Koren R, Katz-Likvornik S, Orshan L, Glatman-Freedman A, Mendelson E.

Clin Microbiol Infect. 2017 Dec;23(12):986-993. doi: 10.1016/j.cmi.2017.04.023. Epub 2017 May 6.

14.

A(H1N1)pdm09 influenza infection: vaccine inefficiency.

Friedman N, Drori Y, Pando R, Glatman-Freedman A, Sefty H, Bassal R, Stein Y, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

Oncotarget. 2017 May 16;8(20):32856-32863. doi: 10.18632/oncotarget.16459.

15.

Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.

Prados-Rosales R, Carreño L, Cheng T, Blanc C, Weinrick B, Malek A, Lowary TL, Baena A, Joe M, Bai Y, Kalscheuer R, Batista-Gonzalez A, Saavedra NA, Sampedro L, Tomás J, Anguita J, Hung SC, Tripathi A, Xu J, Glatman-Freedman A, Jacobs WR Jr, Chan J, Porcelli SA, Achkar JM, Casadevall A.

PLoS Pathog. 2017 Mar 9;13(3):e1006250. doi: 10.1371/journal.ppat.1006250. eCollection 2017 Mar.

16.

Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015-2016 epidemic season in Israel.

Pando R, Drori Y, Friedman N, Glatman-Freedman A, Sefty H, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

J Clin Virol. 2017 Mar;88:12-16. doi: 10.1016/j.jcv.2017.01.002. Epub 2017 Jan 6.

PMID:
28088665
17.

Factors associated with choice of approach for Group B streptococcus screening.

Sefty H, Klivitsky A, Bromberg M, Dichtiar R, Ami MB, Shohat T, Glatman-Freedman A; Israel Obstetric Survey Group (IOSG).

Isr J Health Policy Res. 2016 Nov 15;5:42. eCollection 2016.

18.

Epidemiological and Virological Characterization of Influenza B Virus Infections.

Sharabi S, Drori Y, Micheli M, Friedman N, Orzitzer S, Bassal R, Glatman-Freedman A, Shohat T, Mendelson E, Hindiyeh M, Mandelboim M.

PLoS One. 2016 Aug 17;11(8):e0161195. doi: 10.1371/journal.pone.0161195. eCollection 2016.

19.

Near real-time space-time cluster analysis for detection of enteric disease outbreaks in a community setting.

Glatman-Freedman A, Kaufman Z, Kopel E, Bassal R, Taran D, Valinsky L, Agmon V, Shpriz M, Cohen D, Anis E, Shohat T.

J Infect. 2016 Aug;73(2):99-106. doi: 10.1016/j.jinf.2016.04.038. Epub 2016 Jun 14.

PMID:
27311747
20.

The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.

Prados-Rosales R, Carreño LJ, Weinrick B, Batista-Gonzalez A, Glatman-Freedman A, Xu J, Chan J, Jacobs WR Jr, Porcelli SA, Casadevall A.

J Infect Dis. 2016 Aug 1;214(3):426-37. doi: 10.1093/infdis/jiw153. Epub 2016 Apr 18. Erratum in: J Infect Dis. 2017 Feb 1;215(3):496.

21.

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Chen T, Blanc C, Eder AZ, Prados-Rosales R, Souza AC, Kim RS, Glatman-Freedman A, Joe M, Bai Y, Lowary TL, Tanner R, Brennan MJ, Fletcher HA, McShane H, Casadevall A, Achkar JM.

J Infect Dis. 2016 Jul 15;214(2):300-10. doi: 10.1093/infdis/jiw141. Epub 2016 Apr 7.

22.

Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.

Mandelboim M, Glatman-Freedman A, Drori Y, Sherbany H, Pando R, Sefty H, Zadka H, Shohat T, Keller N, Mendelson E.

Oncotarget. 2016 Jan 12;7(2):1185-92. doi: 10.18632/oncotarget.6746.

23.

Mosquito Surveillance for 15 Years Reveals High Genetic Diversity Among West Nile Viruses in Israel.

Lustig Y, Hindiyeh M, Orshan L, Weiss L, Koren R, Katz-Likvornik S, Zadka H, Glatman-Freedman A, Mendelson E, Shulman LM.

J Infect Dis. 2016 Apr 1;213(7):1107-14. doi: 10.1093/infdis/jiv556. Epub 2015 Nov 23.

PMID:
26597260
24.

Back-to-school upper respiratory infection in preschool and primary school-age children in Israel.

Perry Markovich M, Glatman-Freedman A, Bromberg M, Augarten A, Sefty H, Kaufman Z, Sherbany H, Regev L, Chodick G, Mendelson E, Shohat T, Mandelboim M; Israel Pediatric Upper Respiratory Infection Network (IPURIN).

Pediatr Infect Dis J. 2015 May;34(5):476-81. doi: 10.1097/INF.0000000000000627.

PMID:
25879647
25.

Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis.

Glatman-Freedman A, Portelli I, Jacobs SK, Mathew JI, Slutzman JE, Goldfrank LR, Smith SW.

PLoS One. 2012;7(11):e50228. doi: 10.1371/journal.pone.0050228. Epub 2012 Nov 30. Review.

26.

The effect of social determinants on immunization programs.

Glatman-Freedman A, Nichols K.

Hum Vaccin Immunother. 2012 Mar;8(3):293-301. doi: 10.4161/hv.19003. Epub 2012 Feb 13. Review.

PMID:
22327490
27.

Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice.

Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U, Camara C, Nosanchuk JD, Besra GS, Chen B, Jimenez J, Glatman-Freedman A, Jacobs WR Jr, Porcelli SA, Casadevall A.

J Clin Invest. 2011 Apr;121(4):1471-83. doi: 10.1172/JCI44261.

28.

Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines.

Glatman-Freedman A, Cohen ML, Nichols KA, Porges RF, Saludes IR, Steffens K, Rodwin VG, Britt DW.

PLoS One. 2010 Nov 2;5(11):e13802. doi: 10.1371/journal.pone.0013802.

29.

Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.

Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, Scherer CF, Estes DM, Jacobs WR Jr, Glatman-Freedman A, Larsen MH.

Vaccine. 2007 Nov 7;25(45):7832-40. Epub 2007 Sep 4.

PMID:
17931755
30.

Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.

Al-Sayyed B, Piperdi S, Yuan X, Li A, Besra GS, Jacobs WR Jr, Casadevall A, Glatman-Freedman A.

Tuberculosis (Edinb). 2007 Nov;87(6):489-97. Epub 2007 Sep 19.

31.

Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.

Achkar JM, Casadevall A, Glatman-Freedman A.

Expert Rev Anti Infect Ther. 2007 Jun;5(3):461-74. Review.

PMID:
17547510
32.

Serologic evidence for regional differences in pediatric cryptococcal infection.

Davis J, Zheng WY, Glatman-Freedman A, Ng JA, Pagcatipunan MR, Lessin H, Casadevall A, Goldman DL.

Pediatr Infect Dis J. 2007 Jun;26(6):549-51.

PMID:
17529880
33.

The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.

Glatman-Freedman A.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):191-7. Epub 2006 Apr 3. Review.

PMID:
16584923
34.

Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?

Lang ML, Glatman-Freedman A.

Infect Immun. 2006 Feb;74(2):803-9. Review. No abstract available.

35.

BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments.

Lang GA, Illarionov PA, Glatman-Freedman A, Besra GS, Lang ML.

Int Immunol. 2005 Jul;17(7):899-908. Epub 2005 Jun 20.

PMID:
15967785
36.

Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan.

Glatman-Freedman A, Casadevall A, Dai Z, Jacobs WR Jr, Li A, Morris SL, Navoa JA, Piperdi S, Robbins JB, Schneerson R, Schwebach JR, Shapiro M.

J Clin Microbiol. 2004 Jul;42(7):3225-31.

37.
38.

Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan.

Navoa JA, Laal S, Pirofski LA, McLean GR, Dai Z, Robbins JB, Schneerson R, Casadevall A, Glatman-Freedman A.

Clin Diagn Lab Immunol. 2003 Jan;10(1):88-94.

39.

Infection of mice with aerosolized Mycobacterium tuberculosis: use of a nose-only apparatus for delivery of low doses of inocula and design of an ultrasafe facility.

Schwebach JR, Chen B, Glatman-Freedman A, Casadevall A, McKinney JD, Harb JL, McGuire PJ, Barkley WE, Bloom BR, Jacobs WR Jr.

Appl Environ Microbiol. 2002 Sep;68(9):4646-9.

40.

Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo.

Schwebach JR, Glatman-Freedman A, Gunther-Cummins L, Dai Z, Robbins JB, Schneerson R, Casadevall A.

Infect Immun. 2002 May;70(5):2566-75.

41.

Rubella vaccine.

Glatman-Freedman A.

Pediatr Rev. 2002 Mar;23(3):106-7; discussion 106-7. No abstract available.

PMID:
11875183
42.

Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo.

Schwebach JR, Casadevall A, Schneerson R, Dai Z, Wang X, Robbins JB, Glatman-Freedman A.

Infect Immun. 2001 Sep;69(9):5671-8.

43.
44.

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.

Teitelbaum R, Glatman-Freedman A, Chen B, Robbins JB, Unanue E, Casadevall A, Bloom BR.

Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15688-93.

45.
46.

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z.

Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46.

47.

Simultaneous Pneumocystis carinii and pneumococcal pneumonia in human immunodeficiency virus-infected children.

Glatman-Freedman A, Ewig JM, Dobroszycki J, Mitsudo S, Glaser JH.

J Pediatr. 1998 Jan;132(1):169-71.

PMID:
9470024
48.
49.

Rifampin.

Glatman-Freedman A.

Pediatr Rev. 1996 Aug;17(8):294-5. No abstract available.

PMID:
8758672
50.

Infant botulism.

Glatman-Freedman A.

Pediatr Rev. 1996 May;17(5):185-6. No abstract available.

PMID:
8935918

Supplemental Content

Loading ...
Support Center